共 106 条
[1]
Marcellin P(2009)Hepatitis B and hepatitis C in 2009 Liver Int 29 1-8
[2]
Fattovich G(1998)Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alfa therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol 93 896-900
[3]
Giustina G(2009)High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up J Hepatol 50 1084-1092
[4]
Sanchez-Tapias J(2009)EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 227-242
[5]
Moucari R(2009)Chronic hepatitis B: update 2009 Hepatology 50 1-36
[6]
Korevaar A(2008)Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 263-283
[7]
Lada O(2005)Peginterferon alfa-2a, lamivudine and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 352 2682-2695
[8]
Lok A(2008)Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alfa-2b Gastroenterology 135 459-467
[9]
McMahon B(2004)Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B Hepatology 39 804-810
[10]
Liaw YF(2009)Hepatitis B virus infection Lancet 373 582-592